在患有帕金森病的家族中,一种新的LRRK2变异影响了与RAB8A的结合
Lydia Vela-Desojo1, Alba Pascual2,3, Victor Montal4
1Movement Disorders Unit, Department of Neurology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
NPJ Parkinson's disease
|June 7, 2025
概括
一种新的LRRK2基因变异,p.[Leu119Pro;Leu488Pro],位于ARM域,与家族性帕金森病 (PD) 有关. 这种变异改变了蛋白质相互作用,并可能通过影响LRRK2的功能而导致PD.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 基因中的致病变体是帕金森病 (PD) 的常见遗传原因.
- 影响 armadillo (ARM) 域的 LRRK2 变异可能通过与 RAB 蛋白相互作用间接影响蛋白质活性.
研究的目的:
- 为了研究一种新的LRRK2基因变异,p.[Leu119Pro;Leu488Pro],在一个患有复发性帕金森病的家庭中发现.
- 阐明这种ARM域变体对PD病变产生贡献的分子机制.
主要方法:
- 对9名家庭成员的临床检查.
- 索引案例的神经病理学分析.
- 在分析中,功能性基因组学与重组LRRK2,以及分子对接研究.
主要成果:
- 在一个患有PD的家族中发现了p[Leu119Pro;Leu488Pro]变种.
- 在分析预测了结构和结合性变化.
- 功能性研究显示,LRRK2^Leu119Pro;Leu488Pro与RAB8A.A的相互作用和结合亲和力增加.
结论:
- 新型LRRK2变异p[Leu119Pro;Leu488Pro]被认为是家族性帕金森病的原因.
- 该变体对LRRK2-RAB蛋白相互作用的影响表明PD病变发生的新机制.
相关概念视频
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Overview
492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492
Parkinson's Disease: Treatment
233
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
233
Rab Proteins
3.9K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
3.9K


